Organization | Odontologisk Forskning i Region Skåne (OFRS)

Odontologisk Forskning i Region Skåne (OFRS) Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2016

NCT04662515

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2016

Timeline

NOW

Now

Alternative names

Odontologisk Forskning i Region Skåne (OFRS)

Active Ingredients

Drugs in Other Trials (5)

apixaban (eliquis) (1 trial)

dabigatran (pradaxa) (1 trial)

edoxaban (savaysa) (1 trial)

rivaroxaban (xarelto) (1 trial)

warfarin (coumadin) (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 1
# of Trial APIs: 5